DoseRoutine supplement library logoDoseRoutine
Peptide vial on a dark surface lit by soft blue night light
DoseRoutine Delta Sleep-Inducing Peptide — Peptide vial on a dark surface lit by soft blue night light. Original DoseRoutine photography.
peptideNot an approved drug anywhere; sold, when available at all, as an unregulated research chemicalThe cited literature itself calls DSIP's identity and mechanism an unresolved question, not an established sleep therapeutic

Delta Sleep-Inducing PeptideBenefits, Dosage & Interactions

Also known as: DSIP

Delta Sleep-Inducing Peptide (DSIP) is a naturally occurring nonapeptide (a peptide consisting of nine amino acids) found in the brain and other tissues. It was first isolated from rabbits in 1977 and named for its ability to induce delta wave sleep.

How much Delta Sleep-Inducing Peptide do people take?

The cited reviews describe small human and animal studies from the 1970s-1990s using intravenous DSIP; no consistent dose range is established across them. Route reported: Intravenous infusion in the small human studies discussed; the 2006 review notes its physiological role and even its status as a discrete peptide remain unresolved. Frequency reported: Not consistently reported across the older studies summarized. These are amounts documented in the cited studies and labels for Delta Sleep-Inducing Peptide — they are reported for reference, not a recommendation. Regulatory status differs by country, including between the US (FDA) and Canada (Health Canada). Confirm any amount with a licensed clinician before you take it.

See the full reported protocol and its sources

Researched by DoseRoutine Research TeamReviewed for accuracy by Nicholas Alexander, RSE, SO, PMPLast updated Educational reference only — not medical advice. Always confirm dosing and safety decisions with a licensed clinician.

Evidence: Insufficient — No primary literature attached to this entry yet.
Evidence strengthInsufficient — nothing graded yet
PreclinicalStrong human evidence

No primary literature attached to this entry yet.

Chemical structure of Delta Sleep-Inducing Peptide (PubChem CID 68816)
Structure via PubChem
Plasma half-life
Reported as very short in early animal work, but exact values are inconsistent across studies per the 2006 review
Typical timing
in the evening
Default unit
mg

What published protocols report

Ranges documented in the literature, shown for reference. DoseRoutine does not recommend an amount — your prescriber or the product label sets the dose.

Reported amounts
The cited reviews describe small human and animal studies from the 1970s-1990s using intravenous DSIP; no consistent dose range is established across them[1][2][3]
Route studied
Intravenous infusion in the small human studies discussed; the 2006 review notes its physiological role and even its status as a discrete peptide remain unresolved[1][2][3]
Frequency
Not consistently reported across the older studies summarized[1][2][3]
Cycle length
Not established[1][2][3]
Half-life
Reported as very short in early animal work, but exact values are inconsistent across studies per the 2006 review[1][2][3]
Storage
Not established in the cited sources[1][2][3]

Reported for Delta Sleep-Inducing Peptide in the cited sources. Published ranges are not dosing advice.

Mixing Delta Sleep-Inducing Peptide: bacteriostatic water and syringe units

The vial arrives as dry powder. How much water you add sets the strength, and the strength sets the mark you draw to on the syringe. The table assumes a 5 mg vial and a 250 mcg example draw on a U-100 insulin syringe, where 100 units is one millilitre. If your vial is a different size, scale it — the arithmetic is the same.

Bacteriostatic water addedResulting strength250 mcg draws to
1 mL5 mg/mL5 units
2 mL2.5 mg/mL10 units
3 mL1.67 mg/mL15 units

Units, not millilitres. Insulin syringes are marked in units, and mixing up mcg and mg on a peptide label is the single most common error people report. Check the label twice. Run your own vial through the calculator.

Storage and stability

Before mixing
Sealed and still as a dry powder, Delta Sleep-Inducing Peptide vials are normally kept in the fridge at 2–8 °C, out of light. Short spells at room temperature during shipping are the norm for lyophilized peptides and are not, on their own, a sign the vial is spoiled.
After mixing
Once bacteriostatic water goes in, the vial belongs in the fridge and is generally treated as good for about 28 days — that is how long the benzyl alcohol in bacteriostatic water is relied on to hold back bacterial growth. Plain sterile water has no preservative, so a vial mixed with it is a single-session vial. Never freeze a reconstituted vial.
When to throw it out
A properly mixed vial is clear. Cloudiness, floating strands, a color change or powder that will not go into solution after gentle swirling all mean the vial should be discarded rather than used. Shaking a peptide vial hard is the usual cause — swirl it, or run the water down the inside wall of the vial instead of onto the powder.

Handling and shelf-life figures describe general practice for lyophilized peptides. They are not a dose and not medical advice — your prescriber or the product label sets the amount.

References & evidence

Documents the Delta Sleep-Inducing Peptide entry is written from. Each number matches an inline marker above.

  1. [1]Delta-sleep-inducing peptide (DSIP): a reviewGraf MV, Kastin AJ · Neuroscience and Biobehavioral Reviews · 1984 · Peer-reviewed · PMID 6145137
  2. [2]Delta-sleep-inducing peptide (DSIP): an updateGraf MV, Kastin AJ · Peptides · 1986 · Peer-reviewed · PMID 3550726
  3. [3]Delta sleep-inducing peptide (DSIP): a still unresolved riddleKovalzon VM, Strekalova TV · Journal of Neurochemistry · 2006 · Peer-reviewed · PMID 16539679

References & Evidence

Sources on this page that document Delta Sleep-Inducing Peptide dosing, timing and safety.

  1. [1]National Center for Biotechnology Information View source

Educational information only — not medical advice. Dose ranges vary by person, indication and prescriber.

What is Delta Sleep-Inducing Peptide studied for?

Brain & Cognition

What is Delta Sleep-Inducing Peptide?Sources for this section: Jumps to this entry in the sources and references list at the end of the page.

Delta Sleep-Inducing Peptide (DSIP) is a naturally occurring nonapeptide (a peptide consisting of nine amino acids) found in the brain and other tissues. It was first isolated from rabbits in 1977 and named for its ability to induce delta wave sleep. Research suggests DSIP plays a role in sleep regulation, stress response, and various physiological processes. While present endogenously, synthetic forms of DSIP have been investigated for potential therapeutic applications, particularly in areas related to sleep disturbances and mood regulation. It is typically administered via injection in research settings, due to its peptide nature which would be degraded by oral digestion. (DrugBank)

What does the research say about Delta Sleep-Inducing Peptide?

Tap a section to expand.

The precise mechanism of action of Delta Sleep-Inducing Peptide (DSIP) is not fully understood, but current research suggests it interacts with several neurotransmitter systems and neuronal pathways involved in sleep and stress. DSIP is believed to influence the regulation of the sleep-wake cycle through its effects on the central nervous system. Studies indicate it may modulate the activity of serotonin and dopamine systems, which are key in sleep initiation and maintenance. It is also thought to interact with the opioid system, potentially contributing to its stress-reducing and analgesic properties. DSIP has been shown to cross the blood-brain barrier, allowing it to exert its effects directly on brain structures involved in sleep regulation. Additionally, DSIP may influence neuroendocrine functions, including the release of pituitary hormones, which can indirectly impact sleep and stress responses. (PubChem)

Source for this section: Sources for How does Delta Sleep-Inducing Peptide work?: Jumps to this entry in the sources and references list at the end of the page.

Delta Sleep-Inducing Peptide (DSIP) has been investigated for several potential benefits, primarily related to sleep and neurological function: * **Sleep Regulation**: The most prominent potential benefit of DSIP is its role in sleep induction and regulation. Early research showed its ability to increase delta wave sleep, which is characteristic of deep, restorative sleep. It may help normalize sleep patterns in individuals experiencing sleep disturbances, although more human studies are needed to confirm these effects consistently. (DrugBank) * **Stress Reduction**: Some studies suggest DSIP may have an adaptogenic effect, helping the body cope with stress. It has been observed to influence stress hormone levels and improve behavioral responses to stressful situations in animal models. This could potentially translate to benefits for individuals experiencing chronic stress or anxiety. (PubChem) * **Pain Modulation**: There is some evidence that DSIP may possess analgesic properties and could modulate pain perception. This effect is thought to be partly mediated through its interaction with the opioid system. Further research is required to explore its potential in pain management. (DrugBank) * **Cognitive Function**: By improving sleep quality and reducing stress, DSIP might indirectly support cognitive functions such as memory and concentration. Some animal studies have also explored its potential direct neuroprotective effects, but these findings are preliminary. (PubChem)

Research on Delta Sleep-Inducing Peptide (DSIP) dates back to its discovery in 1977. Early studies, primarily in animals, demonstrated its ability to induce delta wave sleep, which is indicative of deep sleep. A review published in 'Peptides' summarized various animal studies showing DSIP's sedative and sleep-promoting effects, as well as its influence on stress responses and pain. Human studies on DSIP are more limited but have explored its potential in treating insomnia and improving mood. For instance, some small clinical trials have investigated DSIP's use in patients with sleep disorders, showing promising results in normalizing sleep patterns, though larger, more rigorous studies are needed to establish efficacy and safety broadly. (Cochrane Library reviews on specific sleep disorders might mention DSIP in their scope, but a direct Cochrane review on DSIP itself is not readily available as a primary evidence source). Overall, the evidence for DSIP's therapeutic use is still considered largely experimental, with much of the supporting data derived from preclinical animal models. (DrugBank, PubChem)

Given its status as a research peptide, comprehensive human safety data for Delta Sleep-Inducing Peptide (DSIP) are limited. Based on preclinical and limited clinical observations, potential side effects might include: * **Injection site reactions**: As an injectable compound, redness, swelling, or pain at the injection site is possible. * **Drowsiness or altered sleep patterns**: While intended to induce sleep, individual responses can vary, and some might experience excessive drowsiness or paradoxical sleep disturbances. * **Headache** * **Nausea** Long-term side effects and interactions with other medications have not been extensively studied in humans. This is educational information, not medical advice - consult a qualified clinician before starting, stopping or combining any compound.

Due to insufficient human safety data, several warnings are pertinent regarding Delta Sleep-Inducing Peptide (DSIP): * **Lack of Regulatory Approval**: DSIP is not approved by the FDA or similar regulatory bodies for any medical use. Its use is primarily experimental or in research settings. (FDA label for DSIP does not exist) * **Pregnant and Breastfeeding Individuals**: There is no data on the safety of DSIP during pregnancy or lactation. Therefore, it should be avoided by pregnant or breastfeeding individuals. * **Children**: Safety and efficacy in pediatric populations have not been established. * **Underlying Medical Conditions**: Individuals with pre-existing medical conditions, particularly neurological or endocrine disorders, should exercise extreme caution and consult a healthcare professional before considering DSIP, as its effects on these systems are not fully understood. This is educational information, not medical advice - consult a qualified clinician before starting, stopping or combining any compound.

Specific contraindications for Delta Sleep-Inducing Peptide (DSIP) are not well-defined due to the limited scope of human research. However, based on its proposed mechanisms and general pharmacological principles, it would likely be contraindicated in: * **Individuals with known hypersensitivity or allergic reactions** to DSIP or any of its excipients. * **Pregnant or breastfeeding individuals** due to lack of safety data. * **Children**. * **Severe liver or kidney impairment**, as the metabolism and excretion of peptides can be affected, though specific studies on DSIP in these populations are lacking. * **Individuals with severe neurological or psychiatric disorders**, unless carefully evaluated and monitored by a specialist, given its impact on brain activity. This is educational information, not medical advice - consult a qualified clinician before starting, stopping or combining any compound.

Due to the limited research on Delta Sleep-Inducing Peptide (DSIP) in humans, specific drug-drug interactions are not well-documented. However, caution should be exercised when combining DSIP with: * **Sedatives or Hypnotics**: As DSIP is believed to induce sleep, combining it with other sedatives (e.g., benzodiazepines, z-drugs, alcohol) could lead to excessive sedation, respiratory depression, or other adverse effects. The combined effects could be additive or synergistic. * **Antidepressants or Anxiolytics**: Given DSIP's potential influence on neurotransmitter systems (like serotonin and dopamine), combining it with medications affecting these systems could theoretically lead to unpredictable interactions, either enhancing or diminishing their effects, or causing new side effects. * **Opioid Pain Relievers**: DSIP is thought to interact with the opioid system. Concurrent use with opioid analgesics could potentially alter their efficacy or increase side effects. * **Compounds affecting endocrine function**: Due to DSIP's potential influence on pituitary hormones, it may interact with compounds that also affect hormonal balance. Always consult with a qualified clinician before combining DSIP with any other medications or supplements. This is educational information, not medical advice - consult a qualified clinician before starting, stopping or combining any compound.

The typical timing for Delta Sleep-Inducing Peptide (DSIP) administration, when used in research settings for its sleep-inducing properties, is before bedtime. This timing aligns with its intended effect of promoting sleep. Since it is an injectable peptide, its half-life of 1 hour suggests frequent administration might be needed for sustained effects. However, specific dosing protocols are user-directed and must be set by a licensed clinician. It is generally understood that food intake does not significantly impact the efficacy or absorption of injectable peptides like DSIP, so it can be administered either with or without food. (DrugBank)

Source for this section: Sources for When should you take Delta Sleep-Inducing Peptide?: Jumps to this entry in the sources and references list at the end of the page.

Put it into practice

Reading about Delta Sleep-Inducing Peptide is the first step — DoseRoutine helps you act on it. These free tools turn what you just learned into a routine.

What interacts with Delta Sleep-Inducing Peptide?

Documented interactions for Delta Sleep-Inducing Peptide: the other compound, the severity and confidence of the interaction, what happens, and what to do.
Interacts withSeverityTypeWhat happensWhat to do
Any peptide + hormoneNoteCategory ruleConfidence: theoreticalInjectable peptides plus hormones can have overlapping or compounding effects that aren't always well characterized.Source pendingTrack bloodwork with a provider; don't assume combinations are neutral.

Frequently asked questions about Delta Sleep-Inducing Peptide

DSIP is a naturally occurring nonapeptide (a short chain of nine amino acids) found in the brain. It's known for its role in regulating sleep, particularly inducing delta wave sleep, and is also being researched for effects on stress and pain.

Due to its peptide structure, DSIP is typically administered via injection, as oral ingestion would lead to its degradation by digestive enzymes. Specific administration routes (e.g., subcutaneous, intramuscular) depend on the research protocol or clinical guidance.

No, Delta Sleep-Inducing Peptide (DSIP) is not approved by the FDA or any major regulatory body for any medical use. It remains largely a research compound with experimental applications.

The primary potential benefits being investigated include improved sleep regulation (particularly promoting deep delta wave sleep), stress reduction, and potential contributions to pain modulation. Its effects on cognitive function are also an area of interest.

Due to limited human studies, comprehensive side effect data for DSIP is not available. Potential short-term side effects might include injection site reactions, drowsiness, headache, and nausea. Long-term effects are unknown.

As a peptide, Delta Sleep-Inducing Peptide can overlap with other supplements, prescription medicines, hormones and peptides. Because Delta Sleep-Inducing Peptide is usually taken in the evening, most avoidable conflicts come from what else lands in that same window. Risk depends on dose, timing and what else is taken the same day, so each pairing has to be checked rather than assumed safe. The free checker at https://doseroutine.com/interaction-checker covers Delta Sleep-Inducing Peptide with no sign-up.

Delta Sleep-Inducing Peptide is typically taken in the evening. It is administered by injection, so the measured volume — not a tablet count — is the unit that matters. Amounts for this peptide vary by protocol, formulation and individual response, so follow the dose your clinician or the product label specifies.

Whether Delta Sleep-Inducing Peptide fits alongside testosterone replacement therapy depends on the protocol — dose, ester and ancillaries such as HCG or anastrozole — and on current bloodwork. No general contraindication applies across every TRT protocol, so confirm the combination with the prescribing clinician. See the free TRT interaction reference: https://doseroutine.com/trt-supplement-interactions

Published frequency for Delta Sleep-Inducing Peptide varies by protocol and formulation, so the label or prescription is what sets it. It is typically taken in the evening. Frequency is a clinical decision, not a fixed rule — confirm it with the prescriber or product label. Comparison of apps that keep a schedule like this: https://doseroutine.com/best-dose-tracking-apps

The effect of a missed dose of Delta Sleep-Inducing Peptide depends on the protocol and formulation you are on. For injectable protocols, shifting the next injection is usually preferred over doubling it. Follow the missed-dose instructions on your label or from your clinician, and log the miss so the pattern is visible later rather than forgotten.

For an injectable like Delta Sleep-Inducing Peptide the record needs more than a checkbox: vial concentration, the measured volume, and which site the last injection went into. A written log or spreadsheet works for planning but does not remind you or flag conflicts — see the honest comparison at https://doseroutine.com/vs/spreadsheet and the wider roundup at https://doseroutine.com/best-dose-tracking-apps — DoseRoutine tracks the schedule, the remaining supply and interactions with the rest of your routine in one place.

The cited reviews describe small human and animal studies from the 1970s-1990s using intravenous DSIP; no consistent dose range is established across them. Route reported: Intravenous infusion in the small human studies discussed; the 2006 review notes its physiological role and even its status as a discrete peptide remain unresolved. Frequency reported: Not consistently reported across the older studies summarized. These are amounts documented in the cited studies and labels for Delta Sleep-Inducing Peptide — they are reported for reference, not a recommendation. Regulatory status differs by country, including between the US (FDA) and Canada (Health Canada). Confirm any amount with a licensed clinician before you take it.

Which studies looked at Delta Sleep-Inducing Peptide?

Peer-reviewed research indexed in PubMed. Each entry links to the original record.

  1. 1.Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions(opens PubMed in a new tab)J Am Acad Orthop Surg Glob Res Rev · 2026 · PMID 41490200 · https://pubmed.ncbi.nlm.nih.gov/41490200/
  2. 2.Delta sleep-inducing peptide(opens PubMed in a new tab)Eur J Anaesthesiol · 2001 · PMID 11437870 · https://pubmed.ncbi.nlm.nih.gov/11437870/
  3. 3.Peptides and the blood-brain barrier(opens PubMed in a new tab)Peptides · 2015 · PMID 25805003 · https://pubmed.ncbi.nlm.nih.gov/25805003/
  4. 4.Neuropeptides and human sleep(opens PubMed in a new tab)Sleep · 1997 · PMID 9456470 · https://pubmed.ncbi.nlm.nih.gov/9456470/
  5. 5.Delta-sleep-inducing peptide (DSIP): a review(opens PubMed in a new tab)Neurosci Biobehav Rev · 1984 · PMID 6145137 · https://pubmed.ncbi.nlm.nih.gov/6145137/

Sources cited on this page

Specific documents referenced by the numbered markers above. Each number matches the marker in the text.

  1. PubChem CID 68816(opens in a new tab)National Center for Biotechnology Information · pubchem.ncbi.nlm.nih.gov/compound/68816

Verify at

Publisher search links for Delta Sleep-Inducing Peptide. These are places to check the information — they are not citations, so they are not numbered.

DoseRoutine compiles summaries from publicly available scientific and regulatory references. Always verify important decisions with a licensed clinician. How we source and review this information.

What is the short answer on Delta Sleep-Inducing Peptide?

Plain-text summary, safe to quote verbatim:

Delta Sleep-Inducing Peptide (DSIP) is a naturally occurring nonapeptide (a peptide consisting of nine amino acids) found in the brain and other tissues. It was first isolated from rabbits in 1977 and named for its ability to induce delta wave sleep.
Source: DoseRoutine — https://doseroutine.com/library/delta-sleep-inducing-peptide

Delta Sleep-Inducing Peptide cheat sheet

DoseRoutine cheat sheet · Peptide

Delta Sleep-Inducing Peptide

Delta Sleep-Inducing Peptide (DSIP) is a naturally occurring nonapeptide (a peptide consisting of nine amino acids) found in the brain and other tissues. It was first isolated from rabbits in 1977 and named for its ability to induce delta wave sleep.

Evidence

Insufficient

No primary literature attached to this entry yet.

Studied range

The cited reviews describe small human and animal studies from the 1970s-1990s using intravenous DSIP; no consistent dose range is established across them

Route

Intravenous infusion in the small human studies discussed; the 2006 review notes its physiological role and even its status as a discrete peptide remain unresolved

Frequency studied

Not consistently reported across the older studies summarized

Half-life

Reported as very short in early animal work, but exact values are inconsistent across studies per the 2006 review

Timing

in the evening

Storage

Not established in the cited sources

Not an approved drug anywhere; sold, when available at all, as an unregulated research chemicalThe cited literature itself calls DSIP's identity and mechanism an unresolved question, not an established sleep therapeuticBrain

Key references

  1. Delta-sleep-inducing peptide (DSIP): a review (1984)
  2. Delta-sleep-inducing peptide (DSIP): an update (1986)
  3. Delta sleep-inducing peptide (DSIP): a still unresolved riddle (2006)

Studied ranges, not dosing advice. Not medical advice — talk to a clinician. doseroutine.com/library/delta-sleep-inducing-peptide

Cite this page

Using this in an article, AI answer, or research note? Please attribute:

DoseRoutine. (2026). Delta Sleep-Inducing Peptide — Overview, Benefits & Side Effects. Retrieved from https://doseroutine.com/library/delta-sleep-inducing-peptide
Canonical URL

What compounds are similar to Delta Sleep-Inducing Peptide?

Others in the peptide category or studied for the same goals.

Which goals is Delta Sleep-Inducing Peptide used for?

Other compounds studied for the same benefits as Delta Sleep-Inducing Peptide.

Brain & Cognition

See all →

Continue exploring

See every compound DoseRoutine catalogs for these goals.

Brain & Cognition →Full compound library →

Track Delta Sleep-Inducing Peptide in DoseRoutine

Add it to your stack. We'll schedule doses, check interactions against everything else you take, and remind you at the right time.

Sign up free →

Latest research from DoseRoutine

Browse all DoseRoutine research updates

Track Delta Sleep Inducing Peptide in your own routine

Add Delta Sleep Inducing Peptide to your stack, get reminders at the right times, and see interaction notes with everything else you take. Free to start — no card needed.

Track Delta Sleep Inducing Peptide freeSign in